Akizuki S, Ohnishi A, Kotani K, Sudo K (2004) <br />Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form<br /><i>Clinical Chemistry & Laboratory Medicine</i> <b>42</b>: 991<br /><br />Akizuki S, Sudo K, Abe M, Abe I, Nakajima T, Ohnishi A, Maekawa M (1999) <br />[Dibucaine number (DN) and fluoride number (FN) of L330 I mutant recombinant cholinesterase by use of various substrates]<br /><i>Rinsho Byori</i> <b>47</b>: 479<br /><br />Dey DC, Maekawa M, Sudo K, Kanno T (1998) <br />Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes<br /><i>Annals of Clinical Biochemistry</i> <b>35</b>: 302<br /><br />Maekawa M, Sudo K, Dey DC, Ishikawa J, Izumi M, Kotani K, Kanno T (1997) <br />Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan<br /><i>Clinical Chemistry</i> <b>43</b>: 924<br /><br />Sudo K, Maekawa M, Akizuki S, Magara T, Ogasawara H, Tanaka T (1997) <br />Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells<br /><i>Biochemical & Biophysical Research Communications</i> <b>240</b>: 372<br /><br />Sudo K, Maekawa M, Kanno T, Akizuki S, Magara T (1996) <br />Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles<br /><i>Clinical Biochemistry</i> <b>29</b>: 165<br /><br />Maekawa M, Sudo K, Kanno T, Kotani K, Dey DC, Ishikawa J, Izumi M, Etoh K (1995) <br />Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes<br /><i>Clinica Chimica Acta</i> <b>235</b>: 41<br /><br />